Gene therapy

Surendra Nimesh, UGC Assistant Professor at Central University of Rajasthan, Rajasthan, India. Surendra received his M.S. in Biomedical Science from the Dr. B.R. Ambedkar Center for Biomedical Research (ACBR), University of Delhi. He completed his PhD. In Nanotechnology at the Institute of Genomics and Integrative Biology (CSIR), Delhi. After completing his postdoctoral studies at the Ecole Polyetchnique of Montreal, Surendra joined the Clinical Research Institute of Montreal (IRCM), Canada as Postdoctoral Fellow. After completing his commitment at IRCM, he joined McGill University for short time. He also worked as NSERC visiting fellow at Health Canada, Canada. His research interests include nanoparticles-mediated gene, siRNA and drug delivery.

Dedication

List of figures and tables

Acknowledgments

Foreword

Preface

About the author

Chapter 1: Nanotechnology: an introduction

Abstract:

1.1 Introduction

1.2 Definition of nanotechnology

1.3 Structure of the book

Chapter 2: Methods of nanoparticle preparation

Abstract:

2.1 Introduction

2.2 Preparation of nanoparticles by polymerization of monomers

2.3 Preparation of nanoparticles using preformed polymers

2.4 Methods of controlled release

Chapter 3: Tools and techniques for physico-chemical characterization of nanoparticles

Abstract:

3.1 Introduction

3.2 Physico-chemical characterization

Chapter 4: Characterization of nanoparticles: in vitro and in vivo

Abstract:

4.1 Introduction

4.2 In vitro characterization of nanoparticles

4.3 In vivo characterization

4.4 Conclusions

Chapter 5: Theory and limitations to gene therapy

Abstract:

5.1 Introduction

5.2 Mechanism of gene delivery

5.3 Barriers to gene delivery

5.4 Conclusions

Chapter 6: Targeted gene delivery mediated by nanoparticles

Abstract:

6.1 Introduction

6.2 Approaches for targeted gene delivery

6.3 Conclusions

Chapter 7: Polymeric nanoparticles for gene delivery

Abstract:

7.1 Introduction

7.2 Advantages of nanoparticles

7.3 Limitations of nanoparticles

7.4 Conclusions

Chapter 8: Poly-L-lysine nanoparticles

Abstract:

8.1 Introduction

8.2 In vitro and in vivo applications of poly-L-lysine/DNA nanoparticles

8.3 Polylysine-containing peptides for gene delivery

8.4 Conclusions

Chapter 9: Chitosan nanoparticles

Abstract:

9.1 Introduction

9.2 Factors affecting transfection efficiency of chitosan nanoparticles

9.3 Conclusions

Chapter 10: Polyethylenimine nanoparticles

Abstract:

10.1 Introduction

10.2 Derivatives of PEI for in vitro and in vivo gene delivery

10.3 Degradable PEI for gene delivery

10.4 Conclusions

Chapter 11: Atelocollagen

Abstract:

11.1 Introduction

11.2 Atelocollagen-mediated gene delivery

11.3 Conclusions

Chapter 12: Protamine nanoparticles

Abstract:

12.1 Introduction

12.2 Protamine nanoparticles for gene delivery

12.3 Liposome/protamine/ DNA complexes

12.4 Protamine conjugation to other ligands

12.5 Conclusions

Chapter 13: Dendrimers

Abstract:

13.1 Introduction

13.2 Dendrimers in gene delivery

13.3 Conclusions

Chapter 14: Cyclodextrins and cyclodextrin-containing polymers

Abstract:

14.1 Introduction

14.2 Cyclodextrin-embedded polymers

14.3 Polymers with cyclodextrins as pendant groups

14.4 Cyclodextrins as adjuvants for enhanced gene delivery

14.5 Cyclodextrin-based polyrotaxanes

14.6 Conclusions

Chapter 15: Poly(D,L-lactide-co-glycolide)-based nanoparticles

Abstract:

15.1 Introduction

15.2 PLGA nanoparticles for gene delivery

15.3 Chitosan-modified PLGA nanoparticles

15.4 Polyethylenimine-modified PLGA nanoparticles

15.5 Other modifications to PLGA nanoparticles

15.6 Conclusions

Chapter 16: Metallic and inorganic nanoparticles

Abstract:

16.1 Introduction

16.2 Gold nanoparticles

16.3 Mesoporous silica nanoparticles

16.4 MSN for gene delivery

16.5 Polycation-modified MSN for gene delivery

16.6 Conclusions

Index